Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
04/2003
04/08/2003US6544774 Morphological mutants of filamentous fungi
04/08/2003US6544772 Genetic engineering; isolated from Lctobacillus
04/08/2003US6544771 Retroviral gene therapy vectors and therapeutic methods based thereon
04/08/2003US6544769 Compostions comprising viruses and methods for concentrating virus preparations
04/08/2003US6544767 Genetic engineering; isolated polypeptide
04/08/2003US6544766 Genetic engineering; epitope labels
04/08/2003US6544765 Oxaloacetate hydrolase deficient fungal host cells
04/08/2003US6544761 Nucleotide sequences coding polypeptide for use in treatment of restenosis, arthritis and cancer
04/08/2003US6544759 Polynucleotides encoding a novel growth factor which acts through ErbB-4 kinase receptor tyrosine
04/08/2003US6544758 Methods for expressing endostatin protein
04/08/2003US6544757 Genetic engineering; hepatitis virus
04/08/2003US6544755 Method and reagent for treatment of diseases by expression of the c-Myc gene
04/08/2003US6544754 Oplophorus luciferase subunits
04/08/2003US6544753 Dietetics; analgesics; cognition activators; detecting binding
04/08/2003US6544748 Preparation of erythropoietin by endogenous gene activation
04/08/2003US6544746 Combining two double stranded nucleic acid components with the sample wherein each nucleic acid component comprises a portion of a DNA binding element; one nucleic acid is labeled with fluorescence donor other with acceptor; detecting luminescence
04/08/2003US6544741 Sequence determination; genetic engineering
04/08/2003US6544736 Genetic engineering; forming Dna
04/08/2003US6544733 Method of identifying non-host plant disease resistance genes
04/08/2003US6544731 Genetic engineering; binding antibodies
04/08/2003US6544729 Bioluminescent biosensor device
04/08/2003US6544527 Non-infectious, immunogenic, human immunodeficiency virus-like particles devoid of long terminal repeats and a functional pol coding region
04/08/2003US6544523 Mutant forms of Fas ligand and uses thereof
04/08/2003US6544522 Fusion proteins of mycobacterium tuberculosis antigens and their uses
04/08/2003US6544521 Immunoreactive peptide CTL epitopes of human cytomegalovirus pp150
04/08/2003US6544519 Polypeptide originating in haemophilus paragallinarum and process for producing the same
04/08/2003US6544518 Vaccines
04/08/2003US6544516 Treating with anitbodies for bactericidal activity against enterococci
04/08/2003US6544507 Anti-neoplastic viral agents
04/08/2003US6544161 Concurrent spinning a accumulation of samples using rotors
04/08/2003CA2352451C High throughput method for discovery of gene clusters
04/08/2003CA2294305C Antisense oligonucleotide sequences as inhibitors of microorganisms
04/08/2003CA2228046C Root cortex specific gene promoter
04/08/2003CA2191344C Synthetic peptide analogs of lung surfactant protein sp-c
04/08/2003CA2184584C Vascular endothelial growth factor 2
04/08/2003CA2163524C Assay and reagents for identifying anti-proliferative agents
04/08/2003CA2160603C Sequence of the hyaluronan receptor gene
04/08/2003CA2127470C Methods and compositions for diagnosing cat scratch disease and bacillary angiomatosis
04/08/2003CA2109193C Gaba-a receptor subunits (.alpha.-2,.alpha.-3,.alpha.-5,.alpha.-6,.beta.-2) and transfected cells expressing them
04/08/2003CA2107732C Retrovirus from the hiv group and its use
04/08/2003CA2091764C Probe compositions for chromosome identification and methods
04/08/2003CA2008368C Soluble molecule related to but distinct from icam-1
04/08/2003CA2006332C Method of detecting neurological disease or dysfunction
04/04/2003WO2002029063A1 Novel recombinant feline herpesvirus 1 and polyvalent vaccine with the use of the same
04/04/2003CA2424877A1 Novel recombinant feline herpesvirus 1 and polyvalent vaccine with the use of the same
04/03/2003WO2003027991A1 Printed materials comprising a support having an oligomer and/or a polymer applied thereon, a method for preparing the same and a method for delivering and/or storing the same
04/03/2003WO2003027927A1 Dna providing system
04/03/2003WO2003027673A1 Gene inspection apparatus and target nucleic acid extraction method using the same
04/03/2003WO2003027669A2 Method for producing a normalized gene library from nucleic acid extracts of soil samples and the use thereof
04/03/2003WO2003027639A2 Glucocorticoid receptor nuclear translocation domain
04/03/2003WO2003027638A2 Methods for detecting genetic mosaicisms using arrays
04/03/2003WO2003027637A2 Assessment of neurons in the arcuate nucleus to screen for agents that modify feeding behavior
04/03/2003WO2003027632A2 Use of isogenic human cancer cells for high-throughput screening and drug discovery
04/03/2003WO2003027330A1 Rna dependent rna polymerase mediated protein evolution
04/03/2003WO2003027328A2 Methods, kits and compositions pertaining to the suppression of detectable probe binding to randomly distributed repeat sequences in genomic nucleic acid
04/03/2003WO2003027327A1 Antisense modulation of interleukin 8 expression
04/03/2003WO2003027326A2 Nucleic acid sequencing by raman monitoring of molecular deconstruction
04/03/2003WO2003027323A1 Genotyping kit for diagnosis of human papilloma virus infection
04/03/2003WO2003027322A2 Hepatocellular carcinoma-related genes and polypeptides, and method for detecting hepatocellular carcinomas
04/03/2003WO2003027321A2 Methods for diagnosis and treatment of diseases associated with altered expression of neurogranin
04/03/2003WO2003027320A2 Methods for diagnosis and treatment of diseases associated with altered expression of pik3r1
04/03/2003WO2003027319A1 Aptamers containing sequences of nucleic acids or nucleic acid analogues bound homologously, or in novel complexes
04/03/2003WO2003027317A2 Use of active substances for the prophylaxis and/or treatment of diseases caused by cell growth disturbances and test system for discovery of said active substances
04/03/2003WO2003027316A2 Methods of using 33751, a human potassium channel family member
04/03/2003WO2003027313A2 SUPPRESSORS OF CpG OLIGONUCLEOTIDES AND METHODS OF USE
04/03/2003WO2003027311A2 A clone-array pooled shotgun strategy for nucleic acid sequencing
04/03/2003WO2003027310A2 Regulatable, catalytically active nucleic acids
04/03/2003WO2003027309A2 Diagnostic probe detection system
04/03/2003WO2003027308A2 56294 and 56629, novel human metalloproteases and uses thereof
04/03/2003WO2003027307A2 Nucleic acid sequencing by raman monitoring of uptake of precursors during molecular replication
04/03/2003WO2003027306A2 Bgl3 beta-glucosidase and nucleic acids encoding the same
04/03/2003WO2003027301A1 Process for producing alcohol with the use of microorganism
04/03/2003WO2003027300A2 Use of aminoglycoside resistance gene
04/03/2003WO2003027299A2 A plant cyclin dependent kinase-like protein, its interactors and uses thereof
04/03/2003WO2003027298A1 Stem-loop vector system
04/03/2003WO2003027297A1 PROCESS FOR PRODUCING α2,3/α2,8-SIALYLTRANSFERASE AND SIALIC ACID-CONTAINING COMPLEX SUGAR
04/03/2003WO2003027296A1 GENES PARTICIPATING IN THE SYNTHESIS OF FATTY ACID HAVING trans-11-, cis-13- CONDJUGATED DOUBLE BOND AND UTILIZATION THEREOF
04/03/2003WO2003027295A2 Methods for diagnosis and treatment of diseases associated with altered expression of jak1
04/03/2003WO2003027294A1 Glucose dehydrogenase
04/03/2003WO2003027293A1 Biosynthetic genes of blakeslea trispora beta-carotene that code for lycopene cyclase/phytoene synthase (carrp) and phytoene dehydrogenase (carb)
04/03/2003WO2003027291A2 Hdv nucleic acid molecules, fragments and applications thereof
04/03/2003WO2003027290A1 Method of imparting or controlling fertility with the use of fertility restoring gene for rice bt-male sterility cytoplasm and method of judging the existence of fertility restoring gene
04/03/2003WO2003027289A1 Leafhopper ecdysone receptor nucleic acids, polypeptides, and uses thereof
04/03/2003WO2003027288A1 Diagnostic method for cancer characterized in the detection of the deletion of g-csf exon 3
04/03/2003WO2003027287A1 Kidney-specific urate transporter and gene thereof
04/03/2003WO2003027286A1 Method of synthesizing polynucleotide via reverse translation from protein and oligonucleotide to be used in this method
04/03/2003WO2003027285A1 Dna sequences for human angiogenesis genes
04/03/2003WO2003027284A1 Bone metablic disease markers and utilization thereof
04/03/2003WO2003027282A1 Adamts-15, -16, -17, -18 and -19
04/03/2003WO2003027280A1 Gene overexpression system
04/03/2003WO2003027279A1 p300 HISTONE ACETYLASE INHIBITOR
04/03/2003WO2003027278A1 Tailor-made multifunctional stem cells and utilization thereof
04/03/2003WO2003027276A2 Novel compositions and methods for diagnosis and treatment of lymphoma and leukemia
04/03/2003WO2003027272A1 Regulation of human phosphoinositide kinase
04/03/2003WO2003027271A2 Regulation of adenovirus dna packaging by iptg
04/03/2003WO2003027266A2 Whitefly ecdysone receptor nucleic acids, polypeptides, and uses thereof
04/03/2003WO2003027265A2 Composition and methods for enhancing oligonucleotide-directed nucleic acid sequence alteration
04/03/2003WO2003027263A2 Proteins associated with cell growth, differentiation, and death
04/03/2003WO2003027262A2 Biological discovery using gene regulatory networks generated from multiple-disruption expression libraries
04/03/2003WO2003027261A2 Methods and compositions for gene targeting by homologous recombination
1 ... 2550 2551 2552 2553 2554 2555 2556 2557 2558 2559 2560 2561 2562 2563 2564 2565 2566 2567 2568 2569 2570 ... 4023